Cyclopharm Ltd has released a press release.
Investor Presentation Correction
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cyclopharm
- Cyclopharm Investor Update
- Litigation Update and Receipt of Settlement Payment
- Half Year Accounts
- USFDA Approval Process Update
- Cyclopharm 2023 Half Year Accounts Update - Record Revenues
Later from Cyclopharm
- Cyclopharm Receives USFDA Approval for Technegas
- Cyclopharm Signs First USA Contract for Technegas
- Cyclopharm Trading and USA Launch Update
- Cyclopharm to Present at Euroz Hartleys Healthcare Forum
- S&P DJI Announces March 2024 Quarterly Rebalance
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm